Atlas Trials

Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine

Clinical trial NCT06782646 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06782646
Sponsor
The University of Hong Kong
Status
ENROLLING_BY_INVITATION
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hyperlipidemia
Start date
2024-08-01
Primary completion
2025-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.